Board of Directors
Jeffrey L. Adair, Founder, CEO and Chief Technology Officer
Jeff Adair began his career as a medical device design engineer with Medical Dynamics in 1983 after earning his degree in electrical engineering. Jeff directed the engineering department at Medical Dynamics for the next 14 years and assumed the responsibilities associated with the design and development of electronic endoscopes and surgical camera systems. These systems were sold under the Medical Dynamics name as well as OEM systems for some of the largest endoscope companies in the world. Jeff was directly involved with the design and development of many of the innovative products including The 5990 Optical Catheter system, various generations of CCD based surgical camera systems, Xenon and various arc-lamp based light-sources. Jeff was instrumental in developing ground-breaking endoscopic platforms including fiber-based endoscopes for “office arthroscopy” and “office laparoscopy” as well as the industry’s first Electronic Video Laparoscope that integrated the CCD chip into the distal tip of the scope. Jeff also serves as a member of the Board of Directors.
John G. Adair, Founder, Executive Chairman and Chief Financial Officer
John G. Adair currently serves as Executive Chairman and CFO of MIS. He previously served as the Company’s Co-Chief Executive Officer through December 2010. John Adair also previously served in various finance positions including VP-Finance for BaroFold, Inc., a VC-backed biopharmaceutical company focused on developing novel protein therapeutics for Multiple Sclerosis indications, among other indications and Dharmacon, Inc. (a business unit of Thermo-Fisher Scientific), focused on delivering synthesized RNA for the life science market. Prior to joining Dharmacon, Mr. Adair served as a Finance Director at Amgen, Inc. as well as Finance Director and Controller for Akzo-Nobel NV’s generic pharmaceutical division and Controller and Chief Accounting Officer for Medical Dynamics, Inc. (formerly a Nasdaq-traded medical device company). John Adair started his career as an accounting auditor and tax preparer at McGladrey & Pullen, the fifth largest U.S. provider of assurance, tax and consulting services. John Adair received his BS degree in Accounting from Colorado State University and his MS degree in Finance from the University of Colorado. Mr. Adair is a CPA.
David R. Stevens, PhD
David R. Stevens has been a director and chairman of our compensation committee since 2006. He is currently Chairman of Advanced Headache Intervention, Inc., a privately held medical device company, and Cedus, Inc., a privately held biopharmaceutical company. He is also a board member of Aqua Bounty Technologies, Inc., a biotechnology firm listed on the AIM market of the London Stock Exchange. He was an advisor to Bay City Capital from 1999 to 2006. Dr. Stevens was previously President and CEO of Deprenyl Animal Health, Inc., a public veterinary pharmaceutical company, from 1990 to 1998, and Vice President, Research and Development, of Agrion Corp., a private biotechnology company, from 1985 to 1988. He began his career in pharmaceutical research and development at the former Upjohn Company, where he contributed to the preclinical evaluation of Xanax and Halcion. Dr. Stevens received B.S. and DVM degrees from Washington State University, and a Ph.D. in comparative pathology from the University of California, Davis. He is a Diplomate of the American College of Veterinary Pathologists. Dr. Stevens has worked in the pharmaceutical and biotechnology industries since 1978. He brings to the board a diversity of management, operational and product development experience and a unique perspective on the company's business, strategic goals and results of operations.
Ronald A. Lowy
David W. Brenman has served as a director on the Board since 2006 and, until September 2011, was engaged by MIS as its President. Since 1984 Mr. Brenman has served as President, Treasurer and Director of Genesis Solar Corporation. From 1987 to 1988, Mr. Brenman was a Vice President with Lloyds International Corporation, the merchant banking subsidiary of Lloyds Bank Plc. Prior to 1984, Mr. Brenman was an associate with the law firm of Brenman Raskin & Friedlob, P.C. of Denver, Colorado, where he specialized in the fields of taxation and securities law. Mr. Brenman received a B.A. in accounting from the University of Washington, a J.D. from the University of Denver, College of Law and an L.L.M. in taxation from New York University.